RS54912B1 - Farmaceutske formulacije tiokolhikozida sa produženim oslobađanjem - Google Patents

Farmaceutske formulacije tiokolhikozida sa produženim oslobađanjem

Info

Publication number
RS54912B1
RS54912B1 RS20160445A RSP20160445A RS54912B1 RS 54912 B1 RS54912 B1 RS 54912B1 RS 20160445 A RS20160445 A RS 20160445A RS P20160445 A RSP20160445 A RS P20160445A RS 54912 B1 RS54912 B1 RS 54912B1
Authority
RS
Serbia
Prior art keywords
thiocolchicoside
sustained release
release pharmaceutical
pharmaceutical formulations
pharmaceutically acceptable
Prior art date
Application number
RS20160445A
Other languages
English (en)
Inventor
Ali Türkyilmaz
Akalin Nur Pehlivan
Deniz Ömür Durgun
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Publication of RS54912B1 publication Critical patent/RS54912B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Farmaceutska formulacija sa produženim oslobađanjem koja sadrži efektivnu količinu tiokolhikozida ili njegovu farmaceutski prihvatljivu soli kao i glicerol behenat, kao polimer za kontrolu brzine oslobađanja.Prijava sadrži još 14 patentnih zahteva.
RS20160445A 2013-09-12 2014-09-11 Farmaceutske formulacije tiokolhikozida sa produženim oslobađanjem RS54912B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201310731 2013-09-12
EP14184419.1A EP2848259B1 (en) 2013-09-12 2014-09-11 Sustained release pharmaceutical formulations of Thiocolchicoside

Publications (1)

Publication Number Publication Date
RS54912B1 true RS54912B1 (sr) 2016-10-31

Family

ID=50030432

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20160445A RS54912B1 (sr) 2013-09-12 2014-09-11 Farmaceutske formulacije tiokolhikozida sa produženim oslobađanjem

Country Status (7)

Country Link
EP (1) EP2848259B1 (sr)
DK (1) DK2848259T3 (sr)
ES (1) ES2577118T3 (sr)
HU (1) HUE029193T2 (sr)
PL (1) PL2848259T3 (sr)
PT (1) PT2848259E (sr)
RS (1) RS54912B1 (sr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735369B1 (fr) 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
FR2759587B1 (fr) 1997-02-20 1999-03-19 Synthelabo Composition pharmaceutique pour l'administration buccale de thiocolchicoside
FR2774290B1 (fr) 1998-02-05 2000-06-16 Synthelabo Composition pharmaceutique pour l'administration par voie nasale de thiocolchicoside
CN102438597A (zh) * 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂
TR201001903A2 (tr) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Uzatılmış salımlı tiyokolşiklozit tablet.
TR201103752A2 (tr) * 2011-04-18 2012-11-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.

Also Published As

Publication number Publication date
ES2577118T3 (es) 2016-07-13
EP2848259A1 (en) 2015-03-18
HUE029193T2 (en) 2017-02-28
PT2848259E (pt) 2016-06-20
DK2848259T3 (en) 2016-06-27
EP2848259B1 (en) 2016-03-23
PL2848259T3 (pl) 2016-09-30

Similar Documents

Publication Publication Date Title
CY1122695T1 (el) Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
UY36275A (es) Compuestos aminopirimidinilo
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
EA201591805A1 (ru) Оксабицикло [2.2.2] кислоты - модуляторы gpr120
HK1221653A1 (zh) 用於呼吸遞送三種或更多種活性劑的組合物、方法和系統
GT201700023A (es) Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
UY34730A (es) Formulaciones farmacéuticas que comprenden antagonistas de ccr3
RS54238B1 (sr) Formulacije oralnog filma koje sadrže dapoksetin i tadalafil
EA201591397A1 (ru) Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
MX2016001422A (es) Composicion farmaceutica de fingolimod.
UY36761A (es) Formulación oral sólida que contiene irinotecán y método 20 de preparación de la misma
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
MX2019010330A (es) Formulaciones con mejora de la estabilidad.
RS52461B (sr) Kompozicije flupentiksola